Use of Short-Acting Insulin Secretagogues for Type 2 Diabetes Mellitus

Disease Management & Health Outcomes ◽

10.2165/00115677-200513040-00001 ◽

2005 ◽

Vol 13 (4) ◽

pp. 219-224

Author(s):

Maribel Salas ◽

Jamie Banks

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Short Acting ◽

Acting Insulin ◽

Short Acting Insulin ◽

Insulin Secretagogues

Download Full-text

How do short-acting insulin analogues compare with regular human insulin for adults with type 2 diabetes mellitus?

Cochrane Clinical Answers ◽

10.1002/cca.2514 ◽

2019 ◽

Author(s):

Adarsh Gupta

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Human Insulin ◽

Insulin Analogues ◽

Regular Human Insulin ◽

Short Acting ◽

Acting Insulin ◽

Short Acting Insulin

Download Full-text

Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd013228 ◽

2018 ◽

Author(s):

Birgit Fullerton ◽

Andrea Siebenhofer ◽

Klaus Jeitler ◽

Karl Horvath ◽

Thomas Semlitsch ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Human Insulin ◽

Insulin Analogues ◽

Regular Human Insulin ◽

Short Acting ◽

Acting Insulin ◽

Short Acting Insulin

Download Full-text

The Switch from Sulfonylurea to Preprandial Short- Acting Insulin Analog Substitution Has an Immediate and Comprehensive β-Cell Protective Effect in Patients with Type 2 Diabetes Mellitus

Diabetes Technology & Therapeutics ◽

10.1089/dia.2006.8.375 ◽

2006 ◽

Vol 8 (3) ◽

pp. 375-384 ◽

Author(s):

Andreas Pfützner ◽

Babette Lorra ◽

Michel R. Abdollahnia ◽

Peter H. Kann ◽

Dominik Mathieu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Protective Effect ◽

Insulin Analog ◽

Β Cell ◽

Short Acting ◽

Acting Insulin ◽

Short Acting Insulin

Download Full-text

Critical Delay of the Hypoglycemic Effect of Short- Acting Insulin Analogues in Obese Subjects with Type 2 Diabetes Mellitus.

Canadian Journal of Diabetes ◽

10.1016/s1499-2671(08)24026-8 ◽

2008 ◽

Vol 32 (4) ◽

pp. 304

Author(s):

Maude Gagnon-Auger ◽

Jeanpatrice Baillargeon ◽

Elizabeth Martin ◽

Julie Menard ◽

Jean-Luc Ardilouze

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Analogues ◽

Hypoglycemic Effect ◽

Short Acting ◽

Acting Insulin ◽

Short Acting Insulin ◽

Download Full-text

Insulin Glargine 100 Units/mL Alone or in Combination with Short-Acting Insulin in the Management of Uncontrolled Type 2 Diabetes Mellitus: A Prospective Real-Life Study from Egypt (DIAMOND)

The Medical Journal of Cairo University ◽

10.21608/mjcu.2018.56942 ◽

2018 ◽

Vol 86 (6) ◽

pp. 2045-2050

Author(s):

MOHAMED KHATAB, M.D.; MOHAMED REDA, M.D. ◽

MOHAMED ZEITON, M.D.

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Real Life ◽

Acting Insulin ◽

Short Acting Insulin ◽

Real Life Study

Download Full-text

Safety and efficacy of addition of sitagliptin to rapid-acting insulin secretagogues for glycemic control, including post-prandial hyperglycemia, among Japanese with type 2 diabetes mellitus

Diabetology International ◽

10.1007/s13340-015-0230-2 ◽

2015 ◽

Vol 7 (2) ◽

pp. 155-166 ◽

Author(s):

Naoko Tajima ◽

Takashi Kadowaki ◽

Masato Odawara ◽

Toshiomi Minamide ◽

Akiteru Seki ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Safety And Efficacy ◽

Acting Insulin ◽

Insulin Secretagogues

Download Full-text

PDB61 COMPARE LIXISENATIDE WITH RAPID-ACTING INSULIN INTENSIFICATION REGIMENS ON TOP OF BASAL INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A COST PER RESPONDER AND NUMBER NEEDED TO TREAT ANALYSIS IN CHINA

Value in Health ◽

10.1016/j.jval.2019.04.610 ◽

2019 ◽

Vol 22 ◽

pp. S150-S151

Author(s):

P. Men ◽

S. Qu ◽

C. Li ◽

S. Zhai

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Number Needed To Treat ◽

Insulin Intensification ◽

Acting Insulin ◽

Cost Per Responder ◽

Download Full-text

(Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd005613.pub4 ◽

2020 ◽

Author(s):

Thomas Semlitsch ◽

Jennifer Engler ◽

Andrea Siebenhofer ◽

Klaus Jeitler ◽

Andrea Berghold ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Analogues ◽

Nph Insulin ◽

Acting Insulin ◽

Isophane Insulin ◽

Download Full-text

Effects of Rapid-Acting Insulin Analogs on Overall Glycemic Control in Type 1 and Type 2 Diabetes Mellitus

Diabetes Technology & Therapeutics ◽

10.1089/152091503763816472 ◽

2003 ◽

Vol 5 (1) ◽

pp. 57-66 ◽

Author(s):

Smiljana Ristic ◽

Peter C. Bates

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Insulin Analogs ◽

Download Full-text

Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2013.10.003 ◽

2014 ◽

Vol 28 (1) ◽

pp. 40-44 ◽

Author(s):

Denis Raccah ◽

Jay Lin ◽

Edward Wang ◽

Maeva Germé ◽

Riccardo Perfetti ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Randomized Controlled Trials ◽

Basal Insulin ◽

Controlled Trials ◽

Randomized Controlled ◽

Download Full-text